Universal-Beteiligungs- und Servicegesellschaft
NVCR icon

Universal-Beteiligungs- und Servicegesellschaft’s NovoCure NVCR Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Buy
36,652
+1,962
+6% +$29.7K ﹤0.01% 1751
2026
Q1 		$378K Buy
34,690
+6,106
+21% +$76.3K ﹤0.01% 1800
2025
Q4 		$370K Buy
+28,584
New +$367K ﹤0.01% 1798

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's NVCR Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its NovoCure (NVCR) stake by 5.7% in Q2 2026, buying an estimated $29.7K and bringing the position to 36,652 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in NVCR in Q4 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 36,652 shares of NovoCure worth $555K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 1,962 NovoCure shares in Q2 2026, an estimated $29.7K.
  • NovoCure made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1751 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in NovoCure in Q4 2025 and has held it in 3 quarters since.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.